Ovarian Cancer
📧 Sign up to get email alerts when something new happens for Ovarian Cancer.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2013-08-23Clinical Trial Update: Gleevec Study for Patients With Ovarian Cancer [Phase 2]
Phase 2 trial of imatinib (Gleevec) in patients with ovarian cancer has completed and results have been posted.
-
CLINICAL_TRIALS withdrawal · 2013-08-22Clinical Trial Update: Celecoxib in Preventing Cancer in Patients at High Risk for Ovarian Epithelial Cancer Who Are Undergoing Prophylactic Oophorectomy [NA]
The trial evaluating celecoxib to prevent ovarian cancer in BRCA1/BRCA2 mutation carriers undergoing prophylactic oophorectomy has been with…
-
CLINICAL_TRIALS trial_result · 2013-08-20Clinical Trial Update: Laparoscopic Staging in Patients With Ovarian, Fallopian Tube, or Other Primary Abdominal Cancers [Phase 2]
A Phase 2 clinical trial evaluating laparoscopic staging for ovarian, fallopian tube, and other primary abdominal cancers has completed.
-
CLINICAL_TRIALS trial_result · 2013-08-20Clinical Trial Update: Carboplatin-based Chemotherapy With or Without Panitumumab in Platinum-sensitive Recurrent Ovarian Cancer [Phase 2]
Phase 2 clinical trial evaluating carboplatin-based chemotherapy with or without panitumumab for platinum-sensitive recurrent ovarian cancer…
-
CLINICAL_TRIALS trial_result · 2013-08-20Clinical Trial Update: Prospective Evaluation of Lymphoedema Among Patients With Gynaecological Cancer
This is a completed prospective study evaluating lymphedema in patients with gynecologic cancers, including ovarian, cervical, endometrial, …
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS withdrawal · 2013-08-14Clinical Trial Update: Comparison of Standard of Care or Treatment on Protocol [NA]
A terminated clinical trial (NCT01010334) comparing standard of care versus a protocol treatment. The study covers several cancers, includin…
-
CLINICAL_TRIALS trial_result · 2013-08-12Clinical Trial Update: Timing of Surgery and Chemotherapy in Treating Patients With Newly Diagnosed Advanced Ovarian Epithelial, Fallopian Tube, or Primary Peritoneal Cavity Cancer [Phase 2, Phase 3]
This document reports an update on a Phase 2/Phase 3 clinical trial evaluating the timing of surgery and chemotherapy in newly diagnosed adv…
-
CLINICAL_TRIALS trial_result · 2013-08-12Clinical Trial Update: Carboplatin and Paclitaxel With or Without Bevacizumab in Treating Patients With Newly Diagnosed Ovarian Epithelial Cancer, Fallopian Tube Cancer, or Primary Peritoneal Cavity Cancer [Phase 3]
A Phase 3 trial evaluating carboplatin and paclitaxel with or without bevacizumab in newly diagnosed ovarian epithelial cancer, fallopian tu…
-
CLINICAL_TRIALS research · 2013-08-12Clinical Trial Update: Combination Chemotherapy in Treating Patients With Stage II, Stage III, or Stage IV Ovarian Cancer [Phase 2]
A Phase 2 clinical trial evaluating combination chemotherapy for stage II, stage III, or stage IV ovarian cancer has completed.
-
CLINICAL_TRIALS trial_result · 2013-08-12Clinical Trial Update: CA 125 Levels in Treating Patients With Relapsed Advanced Ovarian Cancer, Fallopian Tube Cancer, or Primary Peritoneal Cancer Who Are Receiving Tamoxifen [Phase 2]
This Phase 2 trial update examines CA-125 level monitoring in patients with relapsed advanced ovarian cancer, fallopian tube cancer, or prim…
-
CLINICAL_TRIALS trial_result · 2013-08-07Clinical Trial Update: Carboplatin in Treating Patients With Stage IC-IV Ovarian, Fallopian Tube, or Primary Peritoneal Cancer [Phase 3]
Phase 3 trial evaluating carboplatin for stage IC-IV ovarian cancer, fallopian tube cancer, and primary peritoneal cancer has completed. The…
-
CLINICAL_TRIALS research · 2013-08-07Clinical Trial Update: Combination Chemotherapy With or Without Whole-Body Hyperthermia in Treating Patients With Recurrent Ovarian Epithelial, Fallopian Tube, or Peritoneal Cancer [Phase 2, Phase 3]
This entry describes a Phase 2/3 clinical trial evaluating combination chemotherapy with or without whole-body hyperthermia in patients with…
-
CLINICAL_TRIALS withdrawal · 2013-08-05Clinical Trial Update: Vaccine Therapy in Treating Patients With Metastatic or Recurrent Cancer [Phase 1]
Phase 1 cancer vaccine trial for metastatic or recurrent cancer has been withdrawn.
-
CLINICAL_TRIALS withdrawal · 2013-08-05Clinical Trial Update: CA-125 in Screening Patients at High Risk for Ovarian Cancer
Clinical trial evaluating CA-125 screening for women at high risk of ovarian cancer has been withdrawn.
-
CLINICAL_TRIALS trial_result · 2013-08-02Clinical Trial Update: ZD9331 With or Without Topotecan in Treating Patients With Refractory or Recurrent Epithelial Ovarian Cancer, Fallopian Tube Cancer, or Primary Peritoneal Cancer [Phase 2]
Phase 2 clinical trial evaluating ZD9331 with or without topotecan in patients with refractory or recurrent epithelial ovarian cancer, fallo…
-
CLINICAL_TRIALS trial_result · 2013-08-02Clinical Trial Update: Paclitaxel-Loaded Polymeric Micelle and Carboplatin as First-Line Therapy in Treating Patients With Advanced Ovarian Cancer [Phase 1, Phase 2]
This document reports a Phase 1/2 clinical trial evaluating paclitaxel-loaded polymeric micelle in combination with carboplatin as first-lin…
-
CLINICAL_TRIALS trial_result · 2013-08-02Clinical Trial Update: Levofloxacin to Prevent Infection Following Chemotherapy in Treating Patients With Solid Tumors or Lymphoma [Phase 3]
This document reports a Phase 3 trial update on using levofloxacin to prevent chemotherapy-related infection in patients with solid tumors o…
-
CLINICAL_TRIALS research · 2013-07-31Clinical Trial Update: Elecsys HE4 Chinese Reference Value Study
Clinical trial assessing reference values for the HE4 biomarker (Elecsys HE4) in a Chinese population with ovarian cancer; the study status …
-
CLINICAL_TRIALS withdrawal · 2013-07-24Clinical Trial Update: Whole Abdomen Radiation in Conjunction With Intraperitoneal Chemotherapy for the Treatment of Small Volume Recurrent Ovarian Carcinoma Limited to the Peritoneal Cavity [Phase 1]
A Phase 1 study examining whole-abdomen radiation with intraperitoneal chemotherapy for small-volume recurrent ovarian cancer limited to the…
-
CLINICAL_TRIALS trial_result · 2013-07-19Clinical Trial Update: Alimta® Plus Cisplatin & Paclitaxel Given Intraperitonelly; First Line Tx Stage III Ovarian Cancer [Phase 1]
Phase 1 trial evaluating intraperitoneal delivery of Alimta (pemetrexed) with cisplatin and paclitaxel as first-line therapy for stage III o…
-
CLINICAL_TRIALS trial_result · 2013-07-12Clinical Trial Update: A Study of Carboplatin and DOXIL Plus Bevacizumab in Patients With Platinum Sensitive Recurrent Ovarian, Fallopian Tube and Primary Peritoneal Cancers [Phase 2]
Phase 2 study of carboplatin with DOXIL (liposomal doxorubicin) plus bevacizumab in platinum-sensitive recurrent ovarian, fallopian tube, an…
-
CLINICAL_TRIALS trial_result · 2013-07-10Clinical Trial Update: Carboplatin With or Without Decitabine in Treating Patients With Progressive, Advanced Ovarian Epithelial Cancer, Fallopian Tube Cancer, or Primary Peritoneal Cancer [Phase 2]
A phase 2 trial evaluating carboplatin with or without decitabine in progressive, advanced ovarian epithelial cancer, fallopian tube cancer,…
-
CLINICAL_TRIALS trial_result · 2013-07-09Clinical Trial Update: Combination Chemotherapy With or Without Surgery in Treating Patients With Stage III Ovarian Epithelial Cancer [Phase 3]
A Phase 3 trial evaluating chemotherapy with or without surgery for stage III ovarian epithelial cancer has completed.
-
CLINICAL_TRIALS trial_result · 2013-07-09Clinical Trial Update: Liposomal Doxorubicin and Carboplatin in Treating Patients With Recurrent Ovarian, Fallopian Tube, or Primary Peritoneal Cancer [Phase 1]
Phase 1 clinical trial update of liposomal doxorubicin with carboplatin in patients with recurrent ovarian cancer, fallopian tube cancer, or…
-
CLINICAL_TRIALS trial_result · 2013-07-09Clinical Trial Update: Paclitaxel and Celecoxib in Treating Patients With Recurrent or Persistent Platinum-Resistant Ovarian Epithelial or Primary Peritoneal Cancer [Phase 2]
A Phase 2 clinical trial evaluating the combination of paclitaxel and celecoxib for recurrent or persistent platinum-resistant ovarian epith…